__timestamp | Pharming Group N.V. | Veracyte, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 4042025 | 40786000 |
Thursday, January 1, 2015 | 5279557 | 47876000 |
Friday, January 1, 2016 | 8073913 | 52035000 |
Sunday, January 1, 2017 | 44864073 | 55348000 |
Monday, January 1, 2018 | 53488904 | 65276000 |
Tuesday, January 1, 2019 | 65896361 | 82720000 |
Wednesday, January 1, 2020 | 69968267 | 89118000 |
Friday, January 1, 2021 | 92047281 | 181193000 |
Saturday, January 1, 2022 | 131819000 | 174078000 |
Sunday, January 1, 2023 | 87501000 | 184232000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding the financial dynamics of companies is crucial. Over the past decade, from 2014 to 2023, Pharming Group N.V. and Veracyte, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses.
Pharming Group N.V. started with a modest SG&A expense of approximately $4 million in 2014, which surged to a peak of around $132 million in 2022, marking an impressive increase of over 3,000%. In contrast, Veracyte, Inc. began with $41 million in 2014 and reached $184 million by 2023, reflecting a steady growth of about 350%.
This comparison highlights the strategic financial management and growth trajectories of these companies, offering valuable insights for investors and industry analysts.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Axsome Therapeutics, Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs ACADIA Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and Arrowhead Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Comparing SG&A Expenses: Veracyte, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Breaking Down SG&A Expenses: Veracyte, Inc. vs Viridian Therapeutics, Inc.